Quest Diagnostics Incorporated
Price
FilingsNewest: 10-Q, Quarterly reportJul 23 →InsidersNo open-market buys. 8 insiders sold $28.9M, 22 of 25 sales on a 10b5-1 plan.→HoldersBlackRock 5.7%Vanguard 4.5%Vanguard Portfolio 3.8%→PeersClosest companies: TEM, NEO, MYGN→
From the filings
Figures
- Revenue
- $11.56Blast 12 months
- Net income
- $1.06Blast 12 months
- Operating cash flow
- $1.85Blast 12 months
- Cash and equivalents
- $626.0Mat the last balance sheet
- Total debt
- $5.64Bat the last balance sheet
- Shares outstanding
- 162.0M shareson issue